RASAGILINE JAMP/ RASAGILINE GXMED (AA-Med Pty Ltd)
Product name
RASAGILINE JAMP/ RASAGILINE GXMED
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
131 (255 working days)
Active ingredients
rasagiline mesilate
Registration type
New generic medicine
Indication
Rasagiline is indicated for the symptomatic treatment of idiopathic Parkinson’s disease (PD) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.